Fecal lactoferrin, interleukin-1 beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis

被引:85
作者
Steiner, TS
Flores, CA
Pizarro, TT
Guerrant, RL
机构
[1] UNIV VIRGINIA,HLTH SCI CTR,DIV GEOG & INT MED,CHARLOTTESVILLE,VA 22908
[2] UNIV VIRGINIA,HLTH SCI CTR,DIV INFECT DIS,CHARLOTTESVILLE,VA 22908
[3] UNIV VIRGINIA,HLTH SCI CTR,DIV GASTROENTEROL,CHARLOTTESVILLE,VA 22908
[4] UNIV FED CEARA,FORTALEZA,CEARA,BRAZIL
关键词
D O I
10.1128/CDLI.4.6.719-722.1997
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Twenty-two patients with Clostridium difficile colitis as determined by positive enzyme immunoassay for toxin A were evaluated for fecal inflammatory markers and their relationship to the severity of illness. Fourteen of 22 specimens were positive for fecal lactoferrin (FLF), with titers from 1:50 to 1:800, Nine of 10 stools tested had ratios of interleukin-1 beta (IL-1 beta) to IL-1 receptor antagonist (IL-1ra) of >0.01. Seventeen of 22 specimens also had elevated IL-8 concentrations, and 12 of 14 had elevated IL-1 beta concentrations. A review of the 18 available patient records revealed that fecal IL-8 concentrations, IL-1 beta/IL-1ra ratios, and FLF titers were significantly higher in patients with moderate to severe disease than in patients with mild disease. These findings suggest that the proinflammatory effects of C. difficile may directly influence clinical characteristics of human disease.
引用
收藏
页码:719 / 722
页数:4
相关论文
共 29 条
[1]  
ANAND A, 1994, AM J GASTROENTEROL, V89, P519
[2]  
Bartlett John G., 1995, P893
[3]   CLOSTRIDIUM-DIFFICILE COLITIS - CORRELATION OF CT FINDINGS WITH SEVERITY OF CLINICAL-DISEASE [J].
BOLAND, GW ;
LEE, MJ ;
CATS, AM ;
FERRARO, MJ ;
MATTHIA, AR ;
MUELLER, PR .
CLINICAL RADIOLOGY, 1995, 50 (03) :153-156
[4]   TUMOR-NECROSIS-FACTOR-ALPHA IN STOOL AS A MARKER OF INTESTINAL INFLAMMATION [J].
BRAEGGER, CP ;
NICHOLLS, S ;
MURCH, SH ;
STEPHENS, S ;
MACDONALD, TT .
LANCET, 1992, 339 (8785) :89-91
[5]  
BURAKOFF R, 1995, GASTROENTEROLOGY, V109, P347
[6]  
CASINIRAGGI V, 1995, J IMMUNOL, V154, P2434
[7]   INVOLVEMENT OF RAS-RELATED RHO-PROTEINS IN THE MECHANISMS OF ACTION OF CLOSTRIDIUM-DIFFICILE TOXIN-A AND TOXIN-B [J].
DILLON, ST ;
RUBIN, EJ ;
YAKUBOVICH, M ;
POTHOULAKIS, C ;
LAMONT, JT ;
FEIG, LA ;
GILBERT, RJ .
INFECTION AND IMMUNITY, 1995, 63 (04) :1421-1426
[8]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[9]   VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM BACTEREMIA - RISK-FACTORS FOR INFECTION [J].
EDMOND, MB ;
OBER, JF ;
WEINBAUM, DL ;
PFALLER, MA ;
HWANG, T ;
SANFORD, MD ;
WENZEL, RP .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) :1126-1133
[10]  
FANG GD, 1994, BIOMED J, V1, P71